Nomura Asset Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-7,000
Closed -$683K 934
2015
Q1
$683K Buy
+7,000
New +$683K 0.01% 745